Get Live Data

Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE
GreenRoc Accelerates their World Class Project to Production as Early as 2028
GreenRoc Accelerates their World Class Project to Production as Early as 2028View Video

Latest Share Chat

  2. Share Prices
  3. Genedrive Share Price
  4. Genedrive Share News
  5. IN BRIEF: Genedrive sees acceleration of revenue in 2023

Pin to quick picksGenedrive Share News (GDR)

Genedrive Information

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.53
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.10 (6.897%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.53
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Genedrive sees acceleration of revenue in 2023

Fri, 31st Mar 2023 20:33

Genedrive PLC - Manchester, England-based point-of-care molecular diagnostics company - Reports revenue in the six months to December 31 of GBP20,000 compared to nothing a year prior, and an operating loss of GBP2.7 million from GBP2.8 million. Confident that the company will see an acceleration of revenues through 2023 and going forwards. Agrees GBP5 million equity prepayment facility with Riverfort Global Opportunities PCC Ltd with an initial drawn amount of GBP2 million, expected to be received in early April. Proceeds will be used towards the commercialisation of the antibiotic induced hearing loss test, Genedrive MT-RNR1 ID Kit and enhancing the Genedrive platform as well as providing additional working capital. Directors believe the facility is the best option available at present.

Current stock price: 28.50 pence

12-month change: down 5.0%

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
3 Apr 2018 12:56

Genedrive To Unveil Hepatitis C ID Kit In Singapore Exhibition

LONDON (Alliance News) - Molecular diagnostics firm Genedrive PLC said Tuesday it is to premiere its hepatitis C ID kit in the Asia Pacific at an in will

Read more
20 Mar 2018 13:59

Genedrive Confident For Future As Interim Loss Narrows On Lower Costs

LONDON (Alliance News) - Genedrive PLC said on Tuesday that its pretax loss narrowed in the first half of the financial year as financing costs reduced for six months to the a

Read more
13 Mar 2018 16:10

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 14 March PrudentialFull Year ResultsDignityFull Year MacdonaldHalf 15

Read more
27 Jan 2017 09:42

Genedrive's revenues rise despite difficulties in India

(ShareCast News) - Genedrive, an AIM listed near patient molecular diagnostics diagnostics company, has progressed well in the second half despite difficulties faced with its Tuberculosis (TB) assay in India. Group revenues "significantly" rose to £2.8m for six months ended 31 December 2016, up f

Read more
16 Jan 2017 16:11

Genedrive supplies field test units to US DoD

(ShareCast News) - Manchester-based diagnostics company genedrive announced on Monday that it has supplied Genedrive units and assays to the United States Department of Defense for field trials, as part its $7.8m development programme for a handheld device to allow for the detection of biohazards su

Read more
17 Nov 2016 09:53

Genedrive Human Genotyping Test Gets EU Certification

Read more
11 Oct 2016 14:05

Genedrive's revenue rises while it re-focuses company

(ShareCast News) - AIM-listed molecular diagnostics company Genedrive's revenue grew as it re-focused to concentrate on its Genedrive platform, launched a new test in India and changed its name. For the year ended 30 June, the company, formerly Epistem, reported 12% growth in turnover to £5.1m, comp

Read more
11 Oct 2016 13:11

CORRECT: Genedrive Loss Widens As Product Sales Slow To Materialise

Read more
21 Sep 2016 08:43

Genedrive appoints Matthew Fowler CFO

(ShareCast News) - AIM-listed molecular diagnostic company Genedrive appointed Matthew Fowler as chief financial officer and a member of the board. He will start at a date to be confirmed shortly and will replace John Rylands who has been with company since 2002. Fowler joins Gendrive from Scapa Gr

Read more
2 Aug 2016 09:19

Genedrive Sees Strong Revenue Increase But Wider Annual Loss

Read more
3456789101112

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.